DSC Equity Fund – Healthcare A|A

Reference Data

ISIN AT0000A1FNT0
Valor Number 28871817
Bloomberg Global ID
Fund Name DSC Equity Fund – Healthcare A|A
Fund Provider Dreyfus Söhne & Cie AG, Banquiers Aeschenvorstadt 16 | Postfach
4051 Basel
Schweiz
Phone: +41 61 286 66 66
Web: https://www.dreyfusbank.ch
Fund Provider Dreyfus Söhne & Cie AG, Banquiers
Representative in Switzerland Dreyfus Söhne & Cie AG, Banquiers
Basel
Distributor(s) Dreyfus Söhne & Cie AG, Banquiers
Basel
Asset Class Equities
EFC Category
Distribution Policy Distribution
Home Country Austria
Issuing Condition The fund does not charge any issuing commission and/or fees (units are issued at the NAV)
Redemption Condition The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV)
Investment Strategy *** N/A
Peculiarities

Fund Prices

Current Price * 196.98 CHF 08.09.2025
Previous Price * 198.06 CHF 05.09.2025
52 Week High * 243.90 CHF 17.09.2024
52 Week Low * 186.68 CHF 08.08.2025
NAV * 196.98 CHF 08.09.2025
Issue Price * 202.89 CHF 08.09.2025
Redemption Price * 196.98 CHF 08.09.2025
Closing Price *
Indicative Minimum Price
Fund Assets *** 30,798,117
Unit/Share Assets *** 32,596,169
Trading Information SIX

Performance

YTD Performance -12.02% 30.12.2024
08.09.2025
1 month +5.52% 08.08.2025
08.09.2025
3 months -1.74% 10.06.2025
08.09.2025
6 months -15.94% 10.03.2025
08.09.2025
1 year -17.65% 09.09.2024
08.09.2025
2 years -9.64% 08.09.2023
08.09.2025
3 years -12.26% 08.09.2022
08.09.2025
5 years -7.31% 08.09.2020
08.09.2025

Tax Data

Equity Participation Rate in % 96.01
Share of Total Fund Assets in %
Real Estate Rate in % 0.00
ADDI
ADDI Date

Top 10 Holdings ***

iShares MSCI Wld HlthCrSect AdvcdETF$Inc 7.64%
Eli Lilly and Co 7.05%
Johnson & Johnson 6.73%
Abbott Laboratories 5.15%
AbbVie Inc 4.13%
UnitedHealth Group Inc 3.93%
Merck & Co Inc 3.68%
AstraZeneca PLC 3.35%
Intuitive Surgical Inc 3.19%
Sanofi SA 3.13%
Last data update 30.06.2025

Cost / Risk

TER 1.49%
TER date 30.04.2025
Performance Fee ***
PTR
Max. Management Fee *** 1.50%
Ongoing Charges *** 1.49%
SRRI ***
SRRI date *** 31.07.2025

Breakdowns

Equity Countries ***

Equity Sectors ***

Bond Sectors ***


* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)